Versigent (NYSE:VGNT) Given Average Rating of “Moderate Buy” by Analysts

Versigent (NYSE:VGNT) has received an average rating of “Moderate Buy” from the eleven brokerages that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $46.6667.

Several equities analysts have recently commented on the company. Morgan Stanley assumed coverage on Versigent in a report on Friday, May 8th. They set an “overweight” rating and a $51.00 target price for the company. BNP Paribas Exane started coverage on shares of Versigent in a research note on Tuesday, April 28th. They set an “outperform” rating and a $41.00 target price for the company. Wall Street Zen raised shares of Versigent to a “hold” rating in a research note on Saturday, April 18th. TD Cowen boosted their target price on shares of Versigent from $47.00 to $49.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Finally, Fox Advisors raised shares of Versigent to a “strong-buy” rating in a research note on Tuesday, April 7th.

Versigent Price Performance

NYSE:VGNT opened at $48.29 on Friday. The company’s 50 day moving average is $39.51. Versigent has a 52 week low of $26.34 and a 52 week high of $50.88.

Versigent (NYSE:VGNT) last posted its earnings results on Tuesday, May 5th. The company reported $999.00 EPS for the quarter.